{"entity":{"type":"insider","cik":"0001557082","url":"/insider/0001557082","json_url":"/insider/0001557082.json","name":"Shlevin Harold H.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":11,"first":"2013-11-19","last":"2026-06-30","span_basis":"filed_date"},"name_variants":[{"name":"Shlevin Harold H.","source":"filing","n_filings":11,"first_seen":"2013-11-19","last_seen":"2026-06-30"}],"transactions":[{"id":5957352,"accession":"0001133416-26-000061","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001133416-26-000061","line_url":"/filing/0001133416-26-000061#line-4","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22268.0,"shares_display":"22,268","price_per_share":5.04,"price_display":"5.04","price_state":"stated","total_value":112230.72,"total_display":"112,230.72","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-06-30","scope":"insider"},{"id":5957345,"accession":"0001133416-26-000061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001133416-26-000061","line_url":"/filing/0001133416-26-000061#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7732.0,"shares_display":"7,732","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":38660.0,"total_display":"38,660.00","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":4228610,"accession":"0001133416-25-000067","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001133416-25-000067","line_url":"/filing/0001133416-25-000067#line-3","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19793.0,"shares_display":"19,793","price_per_share":7.038,"price_display":"7.04","price_state":"stated","total_value":139303.134,"total_display":"139,303.13","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-19","scope":"insider"},{"id":4228605,"accession":"0001133416-25-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001133416-25-000067","line_url":"/filing/0001133416-25-000067#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4706.0,"shares_display":"4,706","price_per_share":7.038,"price_display":"7.04","price_state":"stated","total_value":33120.828,"total_display":"33,120.83","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-19","scope":"insider"},{"id":4489637,"accession":"0001133416-25-000064","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001133416-25-000064","line_url":"/filing/0001133416-25-000064#line-3","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8417.0,"shares_display":"8,417","price_per_share":6.3,"price_display":"6.30","price_state":"stated","total_value":53027.1,"total_display":"53,027.10","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-16","scope":"insider"},{"id":4489633,"accession":"0001133416-25-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001133416-25-000064","line_url":"/filing/0001133416-25-000064#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19793.0,"shares_display":"19,793","price_per_share":6.274,"price_display":"6.27","price_state":"stated","total_value":124181.282,"total_display":"124,181.28","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-12","filed_date":"2025-12-16","scope":"insider"},{"id":4489622,"accession":"0001133416-25-000061","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001133416-25-000061","line_url":"/filing/0001133416-25-000061#line-15","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16790.0,"shares_display":"16,790","price_per_share":6.266,"price_display":"6.27","price_state":"stated","total_value":105206.14,"total_display":"105,206.14","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-10","scope":"insider"},{"id":4489614,"accession":"0001133416-25-000061","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001133416-25-000061","line_url":"/filing/0001133416-25-000061#line-13","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":5.962,"price_display":"5.96","price_state":"stated","total_value":119240.0,"total_display":"119,240.00","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":4489606,"accession":"0001133416-25-000061","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001133416-25-000061","line_url":"/filing/0001133416-25-000061#line-11","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":6.019,"price_display":"6.02","price_state":"stated","total_value":210665.0,"total_display":"210,665.00","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":4489601,"accession":"0001133416-25-000061","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001133416-25-000061","line_url":"/filing/0001133416-25-000061#line-10","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":208250.0,"total_display":"208,250.00","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":4489597,"accession":"0001133416-25-000061","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001133416-25-000061","line_url":"/filing/0001133416-25-000061#line-9","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":5.946,"price_display":"5.95","price_state":"stated","total_value":148650.0,"total_display":"148,650.00","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":4489594,"accession":"0001133416-25-000061","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001133416-25-000061","line_url":"/filing/0001133416-25-000061#line-8","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":6.002,"price_display":"6.00","price_state":"stated","total_value":120040.0,"total_display":"120,040.00","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":4489591,"accession":"0001133416-25-000061","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001133416-25-000061","line_url":"/filing/0001133416-25-000061#line-7","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":5.962,"price_display":"5.96","price_state":"stated","total_value":119240.0,"total_display":"119,240.00","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":4489588,"accession":"0001133416-25-000061","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001133416-25-000061","line_url":"/filing/0001133416-25-000061#line-6","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":6.005,"price_display":"6.00","price_state":"stated","total_value":24020.0,"total_display":"24,020.00","shares_owned_after":11206.0,"shares_owned_after_display":"11,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":2209340,"accession":"0001133416-24-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000074","line_url":"/filing/0001133416-24-000074#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":7540.0,"total_display":"7,540.00","shares_owned_after":15206.0,"shares_owned_after_display":"15,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-30","filed_date":"2024-12-31","scope":"insider"},{"id":6851145,"accession":"0001179022-18-000051","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179022-18-000051","line_url":"/filing/0001179022-18-000051#line-3","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30918.0,"shares_display":"30,918","price_per_share":7.7921,"price_display":"7.79","price_state":"stated","total_value":240916.1478,"total_display":"240,916.15","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-13","filed_date":"2018-06-14","scope":"insider"},{"id":6851137,"accession":"0001179022-18-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-18-000051","line_url":"/filing/0001179022-18-000051#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12780.0,"shares_display":"12,780","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":83070.0,"total_display":"83,070.00","shares_owned_after":5374.0,"shares_owned_after_display":"5,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-12","filed_date":"2018-06-14","scope":"insider"},{"id":6229782,"accession":"0001179022-18-000049","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179022-18-000049","line_url":"/filing/0001179022-18-000049#line-4","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10760.0,"shares_display":"10,760","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":69940.0,"total_display":"69,940.00","shares_owned_after":18154.0,"shares_owned_after_display":"18,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-11","filed_date":"2018-06-12","scope":"insider"},{"id":6229779,"accession":"0001179022-18-000049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179022-18-000049","line_url":"/filing/0001179022-18-000049#line-3","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104294.0,"shares_display":"104,294","price_per_share":5.7726,"price_display":"5.77","price_state":"stated","total_value":602047.5444,"total_display":"602,047.54","shares_owned_after":28914.0,"shares_owned_after_display":"28,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-12","scope":"insider"},{"id":6446120,"accession":"0001179022-18-000047","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179022-18-000047","line_url":"/filing/0001179022-18-000047#line-6","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100891.0,"shares_display":"100,891","price_per_share":5.2063,"price_display":"5.21","price_state":"stated","total_value":525268.8133,"total_display":"525,268.81","shares_owned_after":53914.0,"shares_owned_after_display":"53,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-07","filed_date":"2018-06-08","scope":"insider"},{"id":6446106,"accession":"0001179022-18-000047","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179022-18-000047","line_url":"/filing/0001179022-18-000047#line-3","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9078.0,"shares_display":"9,078","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":46751.7,"total_display":"46,751.70","shares_owned_after":53914.0,"shares_owned_after_display":"53,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-06","filed_date":"2018-06-08","scope":"insider"},{"id":6135917,"accession":"0001179022-18-000046","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179022-18-000046","line_url":"/filing/0001179022-18-000046#line-6","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9924.0,"shares_display":"9,924","price_per_share":5.1575,"price_display":"5.16","price_state":"stated","total_value":51183.03,"total_display":"51,183.03","shares_owned_after":53914.0,"shares_owned_after_display":"53,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-06","scope":"insider"},{"id":6135909,"accession":"0001179022-18-000046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179022-18-000046","line_url":"/filing/0001179022-18-000046#line-3","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10907.0,"shares_display":"10,907","price_per_share":5.1502,"price_display":"5.15","price_state":"stated","total_value":56173.2314,"total_display":"56,173.23","shares_owned_after":53914.0,"shares_owned_after_display":"53,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-04","filed_date":"2018-06-06","scope":"insider"},{"id":6009376,"accession":"0001179022-18-000044","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179022-18-000044","line_url":"/filing/0001179022-18-000044#line-5","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69200.0,"shares_display":"69,200","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":352920.0,"total_display":"352,920.00","shares_owned_after":53914.0,"shares_owned_after_display":"53,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-04","scope":"insider"},{"id":6009369,"accession":"0001179022-18-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179022-18-000044","line_url":"/filing/0001179022-18-000044#line-2","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","shares_owned_after":53914.0,"shares_owned_after_display":"53,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-31","filed_date":"2018-06-04","scope":"insider"},{"id":5435320,"accession":"0000914062-13-000324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000324","line_url":"/filing/0000914062-13-000324#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001557082","owner_name":"Shlevin Harold H.","owner_url":"/insider/0001557082","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":6.6299,"price_display":"6.63","price_state":"stated","total_value":3314.95,"total_display":"3,314.95","shares_owned_after":53914.0,"shares_owned_after_display":"53,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-19","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001133416","name":"GALECTIN THERAPEUTICS INC","url":"/issuer/0001133416","role":"Director, Officer (Chief Operating Officer)","n_filings":11,"first_seen":"2013-11-19","last_seen":"2026-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001557082","retrieved_at":"2026-08-21T13:01:13+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}